Physician profile
Bert E Bachrach
NPI 1255388740
$1,061.50
in general payments reported to CMS, 2019-2025
8 companies · $700 in 2025
The $700 reported for 2025 was more than what 96% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $106 · 2023: $112 · 2024: $143 · 2025: $700.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $955.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $955.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $324.80 | 2025 | Omnipod |
| Abbott Laboratories | $240.39 | 2023-2024 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $146.87 | 2025 | |
| Neurocrine Biosciences, INC. | $132.53 | 2025 | |
| Biomarin Pharmaceutical INC. | $90.70 | 2022 | |
| Ascendis Pharma Endocrinology INC | $86.81 | 2022-2025 | Yorvipath |
| Azurity Pharmaceuticals, INC. | $23.93 | 2025 | Zonisade |
| Pfizer INC. | $15.47 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bert Bachrach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.